A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03248843 · COMPLETED
Trial details
- NCT number
- NCT03248843
- Sponsor
- 3D Medicines (Sichuan) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2020-03-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.